Skip to main content

Find Clinical Trials

Home
Conditions
Renal Tumors

Clinical trial condition

Renal Tumors

Explore clinical trials studying Renal Tumors. Study availability and eligibility vary by location and protocol.

6 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Renal Tumors trial results

Recruiting

Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform

NCT06868927

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: IRCCS Ospedale San Raffaele Milan, Italia, Italy

View Trial Details

Recruiting

A Multicenter Study of RUS NE

NCT06868186

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Chonnam National University Hospital Kwangju, Jeollanam-do, South Korea

Asan Medical Center Seoul, South Korea

Samsung Medical Center Seoul, South Korea

Severance Hospital Seoul, South Korea

View Trial Details

Completed

Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors

NCT06969131

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: South Valley university South Valley, Qena Governorate, Egypt

View Trial Details

Completed

Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests

NCT06761742

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Shanghai Jiaotong University School of Medicine, Renji Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

NCT01505569

Conditions: Adenocarcinoma, Atypical Teratoid/Rhabdoid Tumor (AT/RT), Brain Diseases, +48 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Active, Not Recruiting

Imaging-Guided Classification for Endophytic Renal Tumors: PN Strategies & Outcomes

NCT06954571

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: The Second Hospital of Tianjin Medical University Tianjin, Tianjin Municipality, China

View Trial Details